Details for New Drug Application (NDA): 050199
✉ Email this page to a colleague
NDA 050199 describes UNIPEN, which is a drug marketed by Wyeth Ayerst and is included in five NDAs. Additional details are available on the UNIPEN profile page.
The generic ingredient in UNIPEN is nafcillin sodium. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
The generic ingredient in UNIPEN is nafcillin sodium. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
Summary for 050199
| Tradename: | UNIPEN |
| Applicant: | Wyeth Ayerst |
| Ingredient: | nafcillin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050199
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | EQ 250MG BASE/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
